COLUMBUS CIRCLE INVESTORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$8,071,000
-41.0%
80,990
-32.0%
0.44%
-24.5%
Q4 2019$13,687,000
+16.4%
119,122
+27.8%
0.59%
+36.1%
Q3 2019$11,759,000
+29.9%
93,224
+23.9%
0.43%
+78.5%
Q2 2019$9,054,000
-63.4%
75,234
-69.6%
0.24%
-65.5%
Q4 2018$24,744,000
-28.4%
247,320
-18.0%
0.70%
+1.6%
Q3 2018$34,575,000
+47.9%
301,752
+15.8%
0.69%
+42.9%
Q2 2018$23,378,000
+60.3%
260,678
+30.8%
0.48%
+63.2%
Q1 2018$14,581,000199,3030.30%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders